ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 21994751

Gammaretroviral vectors: biology, technology and application.

Maetzig T and 3 others. Viruses, 2011. Cited by 112 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Gammaretroviral vectors: biology, technology and application. Papers, record 21994751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21994751

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gammaretroviral vectors: biology, technology and application.
PubMed
Journal
Viruses
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
112
iCite
Relative citation ratio, by iCite
2.58
iCite
Revised in PubMed
2021-10-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Maetzig TTobias
2Galla MMelanie
3Baum CChristopher
4Schambach AAxel

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genetic TherapyMajor topic
Genetic VectorsMajor topic
Leukemia Virus, MurineMajor topic
Animals
Humans

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References207

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120,688,981Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells.Science2010https://conductscience.org/library/papers/20688981PubMed
28,254,763Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus.J Virol1994https://conductscience.org/library/papers/8254763PubMed
319,826,403Advanced phase I/II studies of targeted gene delivery in vivo: intravenous Rexin-G for gemcitabine-resistant metastatic pancreatic cancer.Mol Ther2010https://conductscience.org/library/papers/19826403PubMed
418,554,410Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors.Retrovirology2008https://conductscience.org/library/papers/18554410PubMed
512,414,981Regulatory mechanisms by which barrier-to-autointegration factor blocks autointegration and stimulates intermolecular integration of Moloney murine leukemia virus preintegration complexes.J Virol2002https://conductscience.org/library/papers/12414981PubMed
62,053,284cis Acting RNA sequences control the gag-pol translation readthrough in murine leukemia virus.Virology1991https://conductscience.org/library/papers/2053284PubMed
78,396,259Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8396259PubMed
88,727,505Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors.Hum Gene Ther1996https://conductscience.org/library/papers/8727505PubMed
911,892,247Improving the post-transcriptional aspects of lentiviral vectors.Curr Top Microbiol Immunol2002https://conductscience.org/library/papers/11892247PubMed
107,823,872Generation of high-titer pseudotyped retroviral vectors with very broad host range.Methods Cell Biol1994https://conductscience.org/library/papers/7823872PubMed

1 to 10 of 207

See all 207 references

Cited by64

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.

PMIDTitleJournalYearIn PapersSource
42,792,667From Delivery to Design: Site-Specific Genome Engineering for Next-Generation CAR T-Cell Therapy.Biomedicines2026https://conductscience.org/library/papers/42792667PubMed
42,290,941Lentiviral rescue of UMPS auxotrophy enables drug-free selection and stable vector expression.Mol Ther Adv2026https://conductscience.org/library/papers/42290941PubMed
42,003,883Reprogramming innate immunity through viral interference: A double-edged strategy for enhancing and containing gene therapies.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42003883PubMed
41,599,088Gammaretrovirus Infections in Humans in the Past, Present, and Future: Have We Defeated the Pathogen?Pathogens2026https://conductscience.org/library/papers/41599088PubMed
41,593,732In vivo engineering of CAR-T cells: delivery strategies and clinical translation.Biomark Res2026https://conductscience.org/library/papers/41593732PubMed
41,445,726In vitro derivation of megakaryocytes and platelets from induced pluripotent stem cells: developmental foundations and translational perspectives.Front Immunol2025https://conductscience.org/library/papers/41445726PubMed
40,871,289Exploring the Use of Viral Vectors Pseudotyped with Viral Glycoproteins as Tools to Study Antibody-Mediated Neutralizing Activity.Microorganisms2025https://conductscience.org/library/papers/40871289PubMed
40,450,520Quantifying the mutational landscape of retroviral and lentiviral vectors in gene therapy patients.Mol Ther2025https://conductscience.org/library/papers/40450520PubMed
40,285,354Clinical hematopoietic stem cell-based gene therapy.Mol Ther2025https://conductscience.org/library/papers/40285354PubMed
39,866,836The design of retroviral vectors used in the CAR-T products, risk management, and future perspective.MedComm (2020)2025https://conductscience.org/library/papers/39866836PubMed

1 to 10 of 64

See all 64 cited by

Genes33

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADA100PubTator's text mininghttps://conductscience.org/library/genes/100NCBI Gene
BANF18,815PubTator's text mininghttps://conductscience.org/library/genes/8815NCBI Gene
CCND2894PubTator's text mininghttps://conductscience.org/library/genes/894NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD464,179PubTator's text mininghttps://conductscience.org/library/genes/4179NCBI Gene
CYBB1,536PubTator's text mininghttps://conductscience.org/library/genes/1536NCBI Gene
FURIN5,045PubTator's text mininghttps://conductscience.org/library/genes/5045NCBI Gene
HBB3,043PubTator's text mininghttps://conductscience.org/library/genes/3043NCBI Gene
HMGB33,149PubTator's text mininghttps://conductscience.org/library/genes/3149NCBI Gene

1 to 10 of 33

See all 33 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21994751

GET https://conductscience.org/api/papers/v1/21994751/references?page=2

API referenceFor AI assistants